NIH Marks $275M for Rare Disease and Extracellular RNA Studies | GenomeWeb

NEW YORK (GenomeWeb News) – The National Institutes of Health has pledged $275 million to fund two multi-year research programs, including studies to discover the causes and cures for rare diseases and how extracellular RNA is involved in disease, NIH said today.

The new strategic funding from NIH's Common Fund includes $145 million for the Undiagnosed Diseases Program, or UDP, and $130 million for the Extracellular RNA Communication program.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.